1st Quarter - Report

FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

BLOCKING Act, Medical device tax, opioids, intellectual property, data exclusivity, CURES, Medicare Part A, B, C, D, Medicaid rebates and inflationary penalties, HR3, Biosimilars, generic medicines, S1391, PDPRA

LobbyistCovered position, as disclosed
SARAH CHRISTINE D'ORSIE —

Bills named: H.R. 3 (116th)

Trade (domestic/foreign) TRD

BLOCKING Act, Medical device tax, opioids, intellectual property, data exclusivity, CURES, Medicare Part A, B, C, D, Medicaid rebates and inflationary penalties, HR3, Biosimilars, generic medicines, S1391, PDPRA

LobbyistCovered position, as disclosed
SARAH CHRISTINE D'ORSIE —

Bills named: H.R. 3 (116th)

Medicare/Medicaid MMM

BLOCKING Act, Medical device tax, opioids, intellectual property, data exclusivity, CURES, Medicare Part A, B, C, D, Medicaid rebates and inflationary penalties, HR3, Biosimilars, generic medicines, S1391, PDPRA

LobbyistCovered position, as disclosed
SARAH CHRISTINE D'ORSIE —

Bills named: H.R. 3 (116th)

Taxation/Internal Revenue Code TAX

BLOCKING Act, Medical device tax, opioids, intellectual property, data exclusivity, CURES, Medicare Part A, B, C, D, Medicaid rebates and inflationary penalties, HR3, Biosimilars, generic medicines, S1391, PDPRA

LobbyistCovered position, as disclosed
SARAH CHRISTINE D'ORSIE —

Bills named: H.R. 3 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.